THTadashi Hoshiyama

Tadashi Hoshiyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tadashi Hoshiyama has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Right Atrial Function as a Novel Predictor for New‐Onset Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy

    byĀ Naoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, Hiroki Usuku, Akihisa Tabira, Hidekazu Kondo, Shotaro Saito, Keisuke Yonezu, Nozomi Kodama, Takuto Zaizen, et al.

    Background: Left atrial functional parameters are established predictors of atrial fibrillation (AF), but the role of right atrial (RA) function, particularly RA peak longitudinal strain (LS), in transthyretin amyloid cardiomyopathy (ATTR‐CM) remains unclear. This study aimed to investigate the relationship between RA function and AF onset in ATTR‐CM. Methods: The derivation cohort comprised 143 patients with ATTR‐CM without prior atrial arrhythmias at Kumamoto University Hospital. Association between baseline parameters and new‐onset AF during the follow‐up period was analyzed using Cox regression models. Discrimination was assessed using time‐dependent receiver operating characteristic analysis at 24 months. Results: During follow‐up (median, 30 months), 42 patients (29%) developed new‐onset AF. Lower RA peak LS was independently associated with incident AF and showed moderate discrimination (time‐dependent area under the curve, 0.72); the optimal cutoff at 24 months was 17.2%. Patients with RA peak LS <17.2% had significantly lower AF‐free survival. A novel risk score integrating RA and left atrial peak LS and LA volume index effectively stratified AF risk. External validation in an independent cohort of 81 patients from Oita and Miyazaki University Hospitals confirmed consistent associations between lower RA peak LS and higher AF incidence, supporting the reproducibility of the findings. Conclusions: RA peak LS is a novel, robust predictor of new‐onset AF in ATTR‐CM and provides additional information alongside established clinical and left atrial parameters. Incorporating RA functional assessment may improve risk stratification and guide early interventions in high‐risk patients.


  • Open Access

    From Working to Retirement-Age ― How Sleep Duration Is Related to Atrial Fibrillation Using 1-Week Holter-Electrocardiogram With Accelerometry ―

    byĀ Tadashi Hoshiyama, Kenichi Tsujita, Yuko Inoue, Masanobu Ishii, Koichiro Kumagai, Takahisa Noma, Kenzaburo Nakajima, Yoshihiro Kokubo, Masatoshi Koga, Naoki Mochizuki, et al.

    Background: Age-specific differences in the association between sleep duration and atrial fibrillation (AF) remain uncertain.Methods and Results: Using the estimated sleep duration derived from accelerometer data embedded in the Holter-electrocardiogram, association between sleep duration and AF was explored among individuals in their 50 s (working-age) and 70s (retirement-age). In the overall population, AF risk decreased with longer sleep, but the benefit diminished with excessively long sleep (P=0.03). Also, consistent risk reduction with increasing sleep was observed in the 50s age group (P=0.02), but not in the 70s.Conclusions: Inadequate sleep may be associated with AF, particularly, among middle-aged individuals.

  • Open Access

    Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non‐Pharmacological Therapy

    byĀ Hisanori Kanazawa, Tadashi Hoshiyama, Shozo Kaneko, Yusei Kawahara, Yuichiro Tsuruta, Yuta Tsurusaki, Kohei Matsunaga, Shunsuke Tamanoi, Naoto Kuyama, Hiroki Usuku, et al.

    In recent years, the number of cases diagnosed with wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) has been increasing. However, ATTRwt‐CM frequently coexists with atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), often necessitating management for arrhythmias. Additionally, ventricular arrhythmias sometimes occur, or conduction disturbances often develop, requiring management for bradycardia, frequently needing device therapy such as pacemakers, implantable cardioverter defibrillators (ICDs), or cardiac resynchronization therapy defibrillators. Therefore, for arrhythmia specialists, who primarily focus on non‐pharmacological treatments, arrhythmias associated with ATTRwt‐CM are unavoidable encounters, and becoming proficient in their management is increasingly important and considered essential. However, we sometimes encounter AF, AFL, or AT that are extremely difficult to treat with catheter ablation, and there are many situations to struggle with: how to manage each arrhythmia and whether catheter ablation should be performed at all. Furthermore, while the usefulness of ICDs for primary prevention of sudden cardiac death remains a subject of debate, we occasionally encounter patients with ventricular arrhythmias in fact. This review primarily addresses and focuses on catheter ablation therapy for atrial arrhythmias associated with ATTRwt‐CM, as well as device therapy for bradyarrhythmias and ventricular arrhythmias, aiming to provide insights for treatment planning in the future as a total management approach to arrhythmia in ATTRwt‐CM patients, especially for arrhythmia specialists.


  • Open Access

    Can Artificial Intelligence Identify the Ideal Ablation Area for the Patients With Atypical Atrial Flutter? A Proof of Concept Study Using Developed Software

    byĀ Motoki Amagasaki, Tadashi Hoshiyama, Takuma Meitoma, Masato Kiyama, Kenji Morihisa, Yuji Ogura, Kenichi Tsujita

    Background: Catheter ablation for atypical atrial flutter (AFL) is challenging owing to its complex circuit. Consequently, the success rate varies depending on the circuit complexity and the operator's level of experience. Objective: This study aimed to create software using artificial intelligence to identify the critical isthmus of atypical AFL on 3D mapping. Methods: Raw data from 19 episodes of atypical AFL were extracted from the 3D mapping system. Local data, including location, activation timing, and voltage amplitude, were used to design software to identify areas where wavefronts converge and conduction slowing (which are characteristics of the optimal treatment area), that is, the critical isthmus, in patients with atypical AFL. Subsequently, the newly developed software was validated by evaluating the concordance between the software‐estimated critical isthmus location and the actual AFL termination area. Results: This newly developed software identified the estimated critical isthmus in all cases in 24.9 (6.7–46.2) seconds. The concordance rate between Top 1 prediction area and actual AFL termination area was high of 79% (95% confidence interval: 56.7%–91.5%). Although 4 of the 19 episodes did not show concordance, it is assumed that ablation at the estimated critical isthmus may have resulted in arrhythmia termination in two cases. Conclusion: This newly developed software identified the optimal treatment area for the atypical AFL with high accuracy. Use of this software may enable faster and more precise treatments. Furthermore, it may allow less experienced operators to achieve results that are comparable to those of experienced operators.

  • Open Access

    Clinical significance of the estimation of pulmonary-right ventricular uncoupling in patients with transthyretin amyloid cardiomyopathy

    byĀ Hiroki Usuku, Eiichiro Yamamoto, Kasumi Miyazaki, Ryudai Higashi, Atsushi Nozuhara, Fumi Oike, Naoto Kuyama, Noriaki Tabata, Masanobu Ishii, Shinsuke Hanatani, et al.

    Aims: There are few data on the prognostic impact of pulmonary-right ventricular (RV) uncoupling in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM). Methods and results: Among the 174 patients who were diagnosed with ATTRwt-CM at Kumamoto University Hospital from 2002 to 2021, 143 patients who met the current Japanese guideline and had sufficient information for two-dimensional speckle tracking echocardiography were retrospectively analysed. During a median follow-up of 1209 days, 39 cardiac deaths occurred. Compared with patients in the non-event group, those in the cardiac death group were significantly older (79.3 ± 6.7 vs. 76.4 ± 6.2, respectively; P < 0.05). Additionally, RV global longitudinal strain (RV-GLS)/systolic pulmonary artery pressure (sPAP), an index of pulmonary-RV uncoupling, was significantly lower in patients in the cardiac death group vs. the non-event group [0.29 (0.18–0.35) vs. 0.40 (0.29–0.57), P < 0.01]. Multivariate Cox proportional hazards regression analysis demonstrated that RV-GLS/sPAP was significantly associated with cardiac death after adjusting for tricuspid annular plane systolic excursion/sPAP (P < 0.01), sPAP (P < 0.05), and conventional prognostic factors including age and hospitalization for heart failure (<0.01), laboratory finding including high-sensitivity cardiac troponin T, and B-type natriuretic peptide (P < 0.01). Receiver operating characteristic analysis showed that the area under the curve for RV-GLS/sPAP for cardiac death was 0.72 and that the best cut off value for RV-GLS/sPAP was 0.34 (sensitivity, 76%; specificity, 65%). In the Kaplan–Meier analysis, patients with ATTRwt-CM who had low vs. high RV-GLS/sPAP (cut-off value 0.34) had a significantly higher probability of cardiac death (P < 0.01). Conclusion: Pulmonary-RV uncoupling has significantly higher prognostic value compared with conventional prognostic factors in ATTRwt-CM.

  • Association Between ALDH2 Genotypes and Atrial Fibrillation Recurrence Following Catheter Ablation: Prospective Multicenter Cohort Study

    byĀ Tadashi Hoshiyama, Keiichi Ashikaga, Kenji Morihisa, Miwa Ito, Kentaro Oniki, Junji Saruwatari, Masanobu Ishii, Hisanori Kanazawa, Hitoshi Sumi, Shozo Kaneko, et al.


  • Impact of the transseptal puncture location on the fossa ovalis on first-pass pulmonary vein isolation

    byĀ Kohei Matsunaga, Tadashi Hoshiyama, Shozo Kaneko, Hitoshi Sumi, Hisanori Kanazawa, Yuta Tsurusaki, Yuichiro Tsuruta, Masanobu Ishii, Shinsuke Hanatani, Hiroki Usuku, et al.


  • Open Access

    Differential impact of diabetes mellitus on in-hospital mortality based on the circadian variation in acute myocardial infarction

    byĀ Kenichi Matsushita, Sunao Kojima, Kyoko Hirakawa, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Tadashi Hoshiyama, Shinsuke Hanatani, Daisuke Sueta, et al.

  • Open Access

    Impact of transseptal puncture location on the fossa ovalis on first-pass pulmonary vein isolation

    byĀ Kohei Matsunaga, Tadashi Hoshiyama, Shozo Kaneko, Hitoshi Sumi, Hisanori Kanazawa, Yuta Tsurusaki, Yuichiro Tsuruta, Masanobu Ishii, Shinsuke Hanatani, Hiroki Usuku, et al.

    Background Recently, radiofrequency catheter ablation (RFCA) has become an important treatment strategy for atrial fibrillation (AF). During this procedure, achieving first-pass pulmonary vein (PV) isolation–PV isolation in which no residual conduction gap remains following initial circumferential lesion is created around the PV–has proven to lead better results in terms of AF recurrence. Although various risk factors for the creation of residual conduction gap have been proposed, the relationship between the transseptal puncture location on fossa ovalis and first-pass PV isolation success rate has not been clarified. Therefore, we investigate the relationship through this investigation. Methods Overall, 102 consecutive patients who had undergone their first RFCA for AF were included. These patients were divided based on the transseptal puncture location (infero-anterior, infero-posterior, supero-anterior, and supero-posterior), which was confirmed by imaging of three-dimensional structure of the anatomical fossa ovalis creating intracardiac echocardiography. The relationship between transseptal puncture location and the first-pass PV isolation success rate was analyzed. Results Among all 102 patients, number of transseptal puncture location were located in infero-anterior, infero-posterior, supero-anterior, and supero-posterior were 26, 61, 6, and 9 respectively. Among these, first-pass PV isolation success rate in the infero-posterior group exhibited the highest 79% (48/61 patients) compared to that in other locations [infero-anterior 61% (16/26 patients), supero-anterior 33% (2/6 patients), and supero-posterior 44% (4/9 patients); P=0.02]. Regarding ablation parameters, although the ablation index was not significantly different between each group (infero-anterior 401.6±7.6, infero-posterior 401.9±5.2, supero-anterior 397.5±4.7, and supero-posterior 398.6±5.3; P = 0.176). The P-vector, which represents insufficient catheter contact, was significantly observed lower frequency in the infero-posterior group (8.6%; P < 0.01) than in the other groups. Conclusion The transseptal puncture location in PV isolation is an important factor to achieve first-pass PV isolation, and it might affect AF recurrence. Non-standard Abbreviations and Acronyms AF, atrial fibrillation; AI, ablation index; FAM, fast anatomical map; PV, pulmonary vein; RFCA, radiofrequency catheter ablation Clinical Perspective What is Known? Although transseptal puncture is an essential technique in atrial fibrillation ablation, the relationship between the transseptal puncture location on the fossa ovalis and first-pass pulmonary vein isolation success rate has not been fully evaluated so far. What the Study Adds Transseptal puncture at the infero-posterior region on the fossa ovalis was shown to result in a higher first-pass PV isolation proportion than that in other locations, owing to the better catheter contact situation. When performing catheter ablation for atrial fibrillation, it should be kept in mind that the transseptal puncture location might affect atrial fibrillation recurrence.